Data / Form D filings / PolyPid Ltd.
PolyPid Ltd.: Form D filings
PolyPid Ltd., a biotechnology company in Petach Tikva, Israel, filed 6 Form D notices with the SEC between 2016 and 2025. The latest, on June 23, 2025, reports $26.7 million sold of a $26.7 million offering to 20 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 18 HASIVIM STREET, Petach Tikva, Israel, 49537
- Phone
- +972-74-719-5700
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Israel
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1611842
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 23, 2025 | New notice | $26,692,799 | $26,692,799 | 20 | Jun 16, 2025 | sec.gov | |
| Jan 2, 2025 | New notice | $14,500,000 | $14,500,000 | 12 | Dec 26, 2024 | sec.gov | |
| Aug 12, 2024 | New notice | $14,200,000 | $14,200,000 | 17 | Aug 6, 2024 | sec.gov | |
| Jan 22, 2024 | New notice | $35,010,120 | $35,010,120 | 20 | Jan 9, 2024 | sec.gov | |
| Sep 16, 2019 | New notice | $50,000,000 | $26,859,292 | $23,140,708 | 361 | Jun 28, 2019 | sec.gov |
| Feb 18, 2016 | New notice | $8,689,377 | $8,135,820 | $553,557 | 8 | Feb 4, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nurit Tweezer-Zaks | Director | |
| Ori Warshavsky | Executive Officer | |
| Yitzchak Jacobovitz | Director | |
| Jonny Missulawin | Executive Officer | |
| Nir Dror | Director | |
| Jacob Harel | Director | |
| Itzhak Krinsky | Director | |
| Robert B. Stein | Director | |
| Dalit Hazan | Executive Officer | |
| Yechezkel Barenholz | Director | |
| Yossi BenAmram | Director | |
| Dikla Czaczkes Akselbrad | Executive Officer |
Every Form D from the week of Jun 23, 2025 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PolyPid Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.